Categories Analysis, Technology

Apple could get hurt in the fight against Huawei

The trade war between the US and China is raging on, and amid this, the US blacklisted a prominent Chinese firm, Huawei Technologies Co. Ltd, last week. Even though the US government has provided some temporary relief, the move has sparked outrage in China.

Now it appears this outrage might have a casualty in the form of Apple Inc. (NASDAQ: AAPL). Huawei has been getting plenty of support from Chinese users on social media with many declaring that they would ditch iPhones in favor of Huawei’s products.

While social media sentiment has a minor role to play in the field of hard-core business, a report by Bloomberg states that if China were to respond to the US with a similar ban on Apple’s products, it would hurt the tech giant’s earnings by 29%.

Earlier this month, a study by IDC showed that during the first quarter of 2019, Huawei surpassed Apple both on smartphone shipment volumes and market share. Huawei held a market share of 19% while Apple had only 11.7%. Huawei managed to grow its shipment volumes by 50% year-over-year while Apple’s shipments fell 30%.

Smartphone shipments and volume for Apple, Huawei, Samsung and Xiaomi

In its second-quarter 2019 earnings announcement, Apple said its sales declined 22% year-over-year in Greater China. China is Apple’s third largest market after the Americas and Europe and accounts for a meaningful portion of its revenue.

Apple already faces tough competition in China from Huawei and other local companies and the ongoing spat is likely to worsen the situation for the iPhone-maker in the region.

Apple’s shares were down 1.7% in afternoon hours on Wednesday.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top